Jupiter Neurosciences, Inc.
JUNSNASDAQHealthcare● Active
$0.23
$-0.00(-0.65%)
Market Cap$8362057
P/E Ratio—
52W High$3.33
52W Low$0.172
Jupiter Neurosciences, Inc. (JUNS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
JUNS · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.06
Est. -$0.05 · -20.0%
Revenue
$0.00B
Est. $0.00B · -91.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
JUNS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.05 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.05 | -$0.06 | -20.0% | $0.00B | $0.00B | -91.7% |
| — Q2 FY2026 | Apr 1, 2026 | -$0.07 | -$0.07 | +0.0% | $0.00B | $0.00B | -70.9% |
| ▲ Q4 FY2025 | Nov 14, 2025 | -$0.08 | -$0.07 | +12.5% | — | — | — |
| — Q3 FY2025 | Aug 18, 2025 | -$0.07 | -$0.07 | +0.0% | — | — | — |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.03 | -$0.05 | -66.7% | — | — | — |
| ▼ Q1 FY2025 | Mar 28, 2025 | -$0.02 | -$0.05 | -150.0% | — | — | — |
| — Q4 FY2024 | Dec 23, 2024 | — | -$0.02 | — | — | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.06
EPS Est.
-$0.05
EPS Surpr.
-20.0%
Revenue
$0.00B
Q2 FY2026
Apr 1, 2026
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2025
Nov 14, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.08
EPS Surpr.
+12.5%
Revenue
—
Q3 FY2025
Aug 18, 2025
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
—
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.05
EPS Est.
-$0.03
EPS Surpr.
-66.7%
Revenue
—
Q1 FY2025
Mar 28, 2025Miss
EPS Actual
-$0.05
EPS Est.
-$0.02
EPS Surpr.
-150.0%
Revenue
—
Q4 FY2024
Dec 23, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q3 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q2 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q1 FY2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Q4 FY2026 | $0.19 | $0.19 | $0.19 | 1 |
| Q3 FY2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -20.0% | $0.34 | $0.35 | +3.89% |
| ▲ Q2 FY2026 | Apr 1, 2026 | +0.0% | $0.38 | $0.38 | +0.93% |
| ▲ Q4 FY2025 | Nov 14, 2025 | +12.5% | $1.31 | $1.34 | +2.29% |
| ▲ Q3 FY2025 | Aug 18, 2025 | +0.0% | $1.29 | $1.24 | -3.88% |
| ▼ Q2 FY2025 | May 15, 2025 | -66.7% | $0.61 | $0.60 | -1.47% |
| ▼ Q1 FY2025 | Mar 28, 2025 | -150.0% | $0.74 | $0.70 | -5.76% |
| — Q4 FY2024 | Dec 23, 2024 | — | $9.73 | $10.95 | +12.54% |
| — Q2 FY2024 | Jun 30, 2024 | — | No price data | $5.49 | — |
Q2 FY2026+3.89%
Report Date
May 14, 2026
EPS Beat/Miss
-20.0%
Price Before
$0.34
Price After
$0.35
Q2 FY2026+0.93%
Report Date
Apr 1, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.38
Price After
$0.38
Q4 FY2025+2.29%
Report Date
Nov 14, 2025
EPS Beat/Miss
+12.5%
Price Before
$1.31
Price After
$1.34
Q3 FY2025-3.88%
Report Date
Aug 18, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.29
Price After
$1.24
Q2 FY2025-1.47%
Report Date
May 15, 2025
EPS Beat/Miss
-66.7%
Price Before
$0.61
Price After
$0.60
Q1 FY2025-5.76%
Report Date
Mar 28, 2025
EPS Beat/Miss
-150.0%
Price Before
$0.74
Price After
$0.70
Q4 FY2024+12.54%
Report Date
Dec 23, 2024
EPS Beat/Miss
—
Price Before
$9.73
Price After
$10.95
Q2 FY2024—
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$5.49
Avg Beat Reaction-0.22%
Avg Miss Reaction-1.11%
Beat Rate3 / 8 quarters
Largest Move+12.54% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: JUNS ends December
Jupiter Neurosciences, Inc. (JUNS) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.06 — missing the analyst consensus of $-0.05 by -20.0%. The next JUNS earnings date is expected around September 1, 2026.
Each quarter, investors track JUNS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. JUNS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
JUNS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
JUNS earnings · 5 questionsJupiter Neurosciences, Inc.'s next earnings report is expected around September 1, 2026. JUNS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; JUNS historically reports after market close (AMC).
JUNS earnings datewhen is JUNS earningsJUNS next earnings datewhen does JUNS report earningsJUNS earnings calendar
▸ Source: FMP · Jupiter Neurosciences, Inc. SEC filings · US GAAP · Jupiter Neurosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026